Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 2004 Apr;48(4):1406–1409. doi: 10.1128/AAC.48.4.1406-1409.2004

Molecular Analysis of Metallo-β-Lactamase Gene blaSPM-1-Surrounding Sequences from Disseminated Pseudomonas aeruginosa Isolates in Recife, Brazil

Laurent Poirel 1, Marcelo Magalhaes 2, Miguel Lopes 2, Patrice Nordmann 1,*
PMCID: PMC375305  PMID: 15047554

Abstract

The spread of clonally related carbapenem-resistant Pseudomonas aeruginosa producing the metallo-β-lactamase SPM-1 was found in Recife, Brazil. Upstream of blaSPM-1, a novel common region (CR4) was identified, comprising an open reading frame, orf495, whose product shares significant identity with putative recombinases, such as Orf513. CR4 may be responsible for mobilization and expression of blaSPM-1.


During the last decade, several acquired carbapenem-hydrolyzing enzymes have been identified in Pseudomonas aeruginosa, beginning with IMP-1 and derivatives, which are widespread in Japan (24, 25) and China (4) and are emerging in Europe and Canada (8, 13). Then, VIM-1 and VIM-2 enzymes were characterized, first in Italy and France (11, 22), respectively, but these enzymes are also highly prevalent in Korea and Greece (7, 14, 29). Recently a third member of acquired Ambler class B β-lactamases, SPM-1, has been identified from a P. aeruginosa isolate in Sao Paulo, Brazil (28).

The aim of this study was to analyze carbapenem-resistant P. aeruginosa isolates recovered from different hospitals in Recife, Brazil, from November 2002 to January 2003. Nineteen P. aeruginosa strains resistant to ceftazidime and imipenem were isolated at the Marcelo Magalhaes clinical laboratory in Recife. Ten isolates were from patients of neurological wards and intensive care units of the Hospital Portugues, Recife, whereas nine strains were from patients hospitalized in similar units from several hospitals in Recife. Eleven imipenem-resistant isolates were identified as metallo-β-lactamase producers by using the double disk-synergy test with EDTA (30), and these were retained for further genetical analysis. They were resistant to all β-lactams except aztreonam. Isoelectric focusing analysis performed as described previously (20) showed that the 11 isolates expressed 3 β-lactamases, with pI values of 6.5, 7.5, and 8.7, the last likely corresponding to the naturally occurring AmpC enzyme of P. aeruginosa. Under standard PCR conditions (20), a series of primers was used for detection of genes encoding Ambler class B β-lactamases of the VIM, IMP, or SPM type as described previously (21). Positive results were obtained using the blaSPM-1-specific primers (SPM-1A, 5′-CTGCTTGGATTCATGGGCGC-3′; SPM-1B, 5′-CCTTTTCCGCGACCTTGATC-3′). The 11 isolates had the same blaSPM-1 gene previously identified in P. aeruginosa (28).

A genotypic comparison of the blaSPM-1-positive P. aeruginosa isolates performed by pulsed-field gel electrophoresis, using restriction enzyme SpeI, revealed that these isolates were clonally related (data not shown) (18, 27). Electroporation of putative plasmid DNA extracts from blaSPM-1-positive P. aeruginosa isolates performed as described previously (19) failed. Using pulsed-field gel electrophoresis and I-CeuI digestion followed by hybridization with PCR-generated probes as previously reported (9), a strong signal (located at ca. 400 kb) was obtained with the blaSPM-1-specific probe for SPM-1-producing P. aeruginosa that did not correspond to one of the bands that hybridized with the 16S ribosomal DNA-specific probe (data not shown). Thus, the blaSPM-1 gene was likely plasmid located. In addition, Southern hybridization experiments with BamHI-restricted DNA of SPM-1-producing P. aeruginosa isolates gave a unique signal (data not shown), indicating that the blaSPM-1 gene was present as a single copy in the P. aeruginosa genome.

To characterize the genetic structures surrounding the blaSPM-1 gene in P. aeruginosa, cloning experiments were performed using whole-cell DNA of a blaSPM-1-positive P. aeruginosa isolate and pBK-CMV as a cloning vector, as described previously (17). Selection of recombinant clones was performed using trypticase soy agar plates containing 100 μg of amoxicillin and 30 μg of kanamycin per ml, and two phenotypes were obtained.

A recombinant clone containing plasmid pMM-1 expressed a β-lactamase with a pI value of 7.5 and possessed the blaSPM-1 gene, which conferred resistance to aminopenicillins, ceftazidime, and cefoxitin and reduced suceptibility to imipenem. Another recombinant clone, containing plasmid pMM-2, expressed a restricted-spectrum oxacillinase with a pI value of 6.5, not inhibited by clavulanic acid. Sequencing revealed a novel class D β-lactamase gene, blaOXA-56, that was part of a blaOXA-10-like gene cassette structure. OXA-56 had three amino acid substitutions compared to OXA-35 (2) and OXA-7 (23).

Sequencing of the 3,312-bp insert of pMM-1 revealed an open reading frame upstream of blaSPM-1 encoding 495 amino acids (Fig. 1). The product of orf495 had 81% amino acid identity with Orf2, identified in the multidrug resistance region of an SXT-type conjugative transposon from Vibrio cholerae (10) and considered a recombinase of the so-called CR2 element (16), 58% identity with OrfA, identified in an Escherichia coli strain (5) and part of the so-called CR3 (16), and 54% identity with Orf513, identified upstream of several antibiotic resistance genes, such as blaCMY-9, blaCTX-M-2, blaCTX-M-9, catA2, dfrA10, and part of the so-called CR1 (1, 3, 6, 15). The definition of these conserved regions (CRs) included right-hand ends exhibiting a degree of identity between the CRs (16). Analysis of the nucleotide sequences located between orf495 and blaSPM-1 revealed a similar 33-bp right-hand boundary, sharing 31, 24, and 24 bp with those of CR3, CR2, and CR1, respectively (Fig. 1). Thus, orf495 may be part of a novel transposable structure called CR4. The putative recombinases of the CRs shared an overall important degree of identity (Fig. 2), whereas their functionality remain to be determined. Partridge and Hall (16) showed that CR1 is able to move by itself by homologous recombination events and that the right-hand end of this structure may be active by incorporating adjacent sequences. Upstream of orf495, the sequence encoding the C-terminal extremity of a putative GroEL chaperonin protein (called GroEL1) was present, with its product sharing 89 and 87% amino acid identity with GroEL proteins from Desulfitobacterium hafniense and Stenotrophomonas maltophilia, respectively, with two hairpin structures likely playing a role in transcription ending (Fig. 1).

FIG. 1.

FIG. 1.

Nucleotide sequence of a 3,775-bp fragment containing the blaSPM-1 gene and made of the 3,312-bp BamHI insert of recombinant plasmid pMM-1 completed by PCR sequencing. The deduced amino acid sequence is designated in single-letter code below the nucleotide sequence. The transcription orientations of the open reading frames are indicated by horizontal arrows. The right-hand boundary of CR4 is shaded in grey. The putative hybrid promoter sequences are underlined, consisting in the −35 region brought by the CR4 element and the −10 region belonging to the blaSPM-1 gene. The orf495 transposase gene of CR4 is indicated, as well as the two partial sequences of the groEL gene. The stars indicates stop codons, and a vertical arrow indicates the crossover point of the CR4-mediated putative recombination event. The hairpin structures are boxed and marked with head-to-head arrows. Another vertical arrow (position 3312) indicates the extremity of the cloned fragment in pMM-1.

FIG. 2.

FIG. 2.

Comparison of the amino acid sequences of the different recombinases, consisting in Orf495 from CR4, Orf2 from CR3, Orf513 from CR1, and OrfA from CR2 (15). Stars indicate residues that are identical for the four proteins.

Downstream of blaSPM-1, sequence encoding an N-terminally truncated part of a similar protein (called GroEL2) was present (Fig. 1). PCR experiments using primers designed from the sequence reported by Toleman et al. (28) in combination with SPM-1A followed by sequencing revealed perfect identity with sequences identified in the blaSPM-1-positive P. aeruginosa strain 48-1997A, starting with a 16-bp-long hairpin structure located just after the putative recombination crossover point (Fig. 1). The C-terminal extremity of the GroEL2-encoding sequence present downstream of blaSPM-1 was very similar (94% nucleotide identity) to that of GroEL1 (Fig. 1). In addition, the noncoding sequences located downstream of both groEL genes were identical. Surprisingly, the 5′ end of orf495 was identified in the 3′-end extremity of the groEL2 gene in our sequence, as well as in that reported by Toleman et al. (28). Thus, at least part of orf495 is also present on both sides of blaSPM-1 (Fig. 1).

These data indicated a possible duplication of part of the target genetic structures subsequent to a mobilization process that could result, as suggested (16), from a one-ended mobilization event enhancing the spread of blaSPM-1.

The genetic structures involved in this mobilization process may also enhance expression of the adjacent antibiotic resistance genes, as demonstrated for insertion sequence elements (12). Indeed, analysis of the 220 bp separating orf495 from blaSPM-1 revealed putative promoter sequences made of a −35 motif (TTGAAT) provided by the CR4 boundary and a putative original −10 motif (TACAAT) of blaSPM-1, constituting a hybrid promoter (Fig. 1).

Finally, the origin of this novel element, CR4, has to be determined, since orf495 is not present at least in the P. aeruginosa PAO1 genome (26). Although blaSPM-1 has a GC content of 48%, that of orf495 is 70%, consistent with a Pseudomonaceae origin.

This study describes a novel genetic element associated with a metallo-β-lactamase gene that may constitute a tool for its dissemination.

Nucleotide sequence accession numbers.

The sequences determined in this study have been assigned GenBank sequence accession no. AY341249 (for blaSPM-1) and AY445080 (for blaOXA-56).

Acknowledgments

This work was funded by a grant from the Ministère de l'Education Nationale et de la Recherche (UPRES-EA3539), Université Paris XI, Paris, France.

We thank Marisa Castro for technical assistance. L.P. is a researcher from the INSERM.

REFERENCES

  • 1.Arduino, S. M., P. H. Roy, G. A. Jacoby, B. E. Orman, S. A. Pineiro, and D. Centron. 2002. blaCTX-M-2 is located in an unusual class 1 integron (In35) which includes Orf513. Antimicrob. Agents Chemother. 46:2303-2306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Aubert, D., L. Poirel, A. Ben Ali, F. W. Goldstein, and P. Nordmann. 2001. OXA-35 is an OXA-10-related β-lactamase from Pseudomonas aeruginosa. J. Antimicrob. Chemother. 48:717-721. [DOI] [PubMed] [Google Scholar]
  • 3.Boyd, D., G. A. Peters, A. Cloeckaert, K. S. Boumedine, E. Chaslus-Dancla, H. Imberechts, and M. R. Mulvey. 2002. Complete nucleotide sequence of a 43-kilobase genomic island associated with the multidrug resistance region of Salmonella enterica serovar Typhimurium DT104 and its identification in phage type DT120 and serovar Agona. J. Bacteriol. 183:5725-5732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Chu, Y. W., M. Afzal-Shah, E. T. Houang, M. I. Palepou, D. J. Lyon, N. Woodford, and D. M. Livermore. 2001. IMP-4, a novel metallo-β-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998. Antimicrob. Agents Chemother. 45:710-714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Cloeckaert, A., S. Baucheron, G. Flaujac, S. Schwarz, C. Kehrenberg, J. L. Martel, and E. Chaslus-Dancla. 2000. Plasmid-mediated florfenicol resistance encoded by the floR gene in Escherichia coli isolated from cattle. Antimicrob. Agents Chemother. 44:2858-2860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Di Conza, J., J. A. Ayala, P. Power, M. Mollerach, and G. Gutkind. 2002. Novel class 1 integron (InS21) carrying blaCTX-M-2 in Salmonella enterica serovar Infantis. Antimicrob. Agents Chemother. 46:2257-2261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Giakkoupi, P., G. Petrikkos, L. S. Tzouvelekis, S. Tsonas, N. J. Legakis, A. C. Vatopoulos, and the WHONET Greece Study Group. 2003. Spread of integron-associated VIM-type metallo-β-lactamase genes among imipenem-nonsusceptible Pseudomonas aeruginosa strains in Greek hospitals. J. Clin. Microbiol. 41:822-825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Gibb, A. P., C. Tribuddharat, R. A. Moore, T. J. Louie, W. Krulicki, D. M. Livermore, M. F. Palepou, and N. Woodford. 2002. Nosocomial outbreak of carbapenem-resistant Pseudomonas aeruginosa with a new blaIMP allele, blaIMP-7. Antimicrob. Agents Chemother. 46:255-258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Héritier, C., L. Poirel, D. Aubert, and P. Nordmann. 2003. Genetic and functional analysis of the chromosome-encoded carbapenem-hydrolyzing oxacillinase OXA-40 of Acinetobacter baumannii. Antimicrob. Agents Chemother. 47:268-273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Hochhut, B., Y. Lotfi, D. Mazel, S. M. Faruque, R. Woodgate, and M. K. Waldor. 2001. Molecular analysis of antibiotic resistance gene clusters in Vibrio cholerae O139 and O1 SXT constins. Antimicrob. Agents Chemother. 45:2991-3000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Lauretti, L., M. L. Riccio, A. Mazzariol, G. Cornaglia, G. Amicosante, R. Fontana, and G. M. Rossolini. 1999. Cloning and characterization of blaVIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob. Agents Chemother. 43:1584-1590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Mahillon, J., and M. Chandler. 1998. Insertion sequences. Microbiol. Mol. Biol. Rev. 62:725-774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Nordmann, P., and L. Poirel. 2002. Emerging carbapenemases in Gram-negative aerobes. Clin. Microbiol. Infect. 8:321-331. [DOI] [PubMed] [Google Scholar]
  • 14.Oh, E. J., S. Lee, Y. J. Park, J. J. Park, K. Park, S. I. Kim, M. W. Kang, and B. K. Kim. 2003. Prevalence of metallo-β-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii in a Korean University hospital and comparison of screening methods for detecting metallo-β-lactamase. J. Microbiol. Methods 54:411-418. [DOI] [PubMed] [Google Scholar]
  • 15.Parsons, Y., R. M. Hall, and H. W. Stokes. 1991. A new trimethoprim resistance gene, dhfrX, in the In7 integron of plasmid pDG0100. Antimicrob. Agents Chemother. 35:2436-2439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Partridge, S. R., and R. M. Hall. 2003. In34, a complex In5 family class 1 integron containing orf513 and dfrA10. Antimicrob. Agents Chemother. 47:342-349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Poirel, L., D. Girlich, T. Naas, and P. Nordmann. 2001. OXA-28, an extended-spectrum variant of OXA-10 β-lactamase from Pseudomonas aeruginosa and its plasmid- and integron-located gene. Antimicrob. Agents Chemother. 45:447-453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Poirel, L., G. F. Weldhagen, C. De Champs, and P. Nordmann. 2002. A nosocomial outbreak of Pseudomonas aeruginosa isolates expressing the extended-spectrum β-lactamase GES-2 in South Africa. J. Antimicrob. Chemother. 49:561-565. [DOI] [PubMed] [Google Scholar]
  • 19.Poirel, L., G. F. Weldhagen, T. Naas, C. De Champs, M. G. Dove, and P. Nordmann. 2001. GES-2, a class A β-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem. Antimicrob. Agents Chemother. 45:2598-2603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Poirel, L., I. Le Thomas, T. Naas, A. Karim, and P. Nordmann. 2000. Biochemical sequence analyses of GES-1, a novel class A extended-spectrum β-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrob. Agents Chemother. 44:622-632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Poirel, L., and P. Nordmann. 2002. Acquired carbapenem-hydrolyzing β-lactamases and their genetic support. Curr. Pharm. Biotechnol. 3:117-127. [DOI] [PubMed] [Google Scholar]
  • 22.Poirel, L., T. Naas, D. Nicolas, L. Collet, S. Bellais, J. D. Cavallo, and P. Nordmann. 2000. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother. 44:891-897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Scoulica, E., A. Aransay, and Y. Tselentis. 1995. Molecular characterization of the OXA-7 β-lactamase gene. Antimicrob. Agents Chemother. 39:1379-1382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Senda, K., Y. Arakawa, S. Ichiyama, K. Nakashima, H. Ito, S. Ohsuka, K. Shimokata, N. Kato, and M. Ohta. 1996. PCR detection of metallo-β-lactamase gene (blaIMP) in gram-negative rods resistant to broad-spectrum β-lactams. J. Clin. Microbiol. 34:2909-2913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Senda, K., Y. Arakawa, K. Nakashima, H. Ito, S. Ichiyama, K. Shimokata, N. Kato, and M. Ohta. 1996. Multifocal outbreaks of metallo-β-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum β-lactams, including carbapenems. Antimicrob. Agents Chemother. 40:349-353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Stover, C. K., X. Q. Pham, A. L. Erwin, S. D. Mizoguchi, P. Warrener, M. J. Hickey, F. S. Brinkman, W. O. Hufnagle, D. J. Kowalik, M. Lagrou, R. L. Garber, L. Goltry, E. Tolentino, S. Westbrock-Wadman, Y. Yuan, L. L. Brody, S. N. Coulter, K. R. Folger, A. Kas, K. Larbig, R. Lim, K. Smith, D. Spencer, G. K. Wong, Z. Wu, I. T. Paulsen, J. Reizer, M. H. Saier, R. E. Hancock, S. Lory, M. V. Olson. 2000. Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature 406:959-964. [DOI] [PubMed] [Google Scholar]
  • 27.Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Toleman, M. A., A. M. Simm, T. A. Murphy, A. C. Gales, D. J. Biedenbach, R. N. Jones, and T. R. Walsh. 2002. Molecular characterization of SPM-1, a novel metallo-β-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme. J. Antimicrob. Chemother. 50:673-679. [DOI] [PubMed] [Google Scholar]
  • 29.Tsakris, A., S. Pournaras, N. Woodford, M. F. Palepou, G. S. Babini, J. Douboyas, and D. M. Livermore. 2000. Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. J. Clin. Microbiol. 38:1290-1292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Yong, D., K. Lee, J. H. Yum, H. B. Shin, G. M. Rossolini, and Y. Chong. 2002. Imipenem-EDTA disk method for differentiation of metallo-β-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol. 40:3798-3801. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES